$ORGO stock is up 14% today. Here's what we see in our data. - Nasdaq
5 weeks ago • Google News
Organogenesis Holdings Inc (ORGO)
US$ 3.7-4.88%
Price Chart
Key Statistics
Market Cap
$ 539.13M
P/E Ratio
0.00
Revenue (TTM)
$ 458.76M
Volume
1.1M
52W High
$ 6.71
52W Low
$ 2.28
Dividend Yield
0.00%
Beta
1.64
Technicals
50-Day MA
3.6213
200-Day MA
3.665
52 Week High
6.71
52 Week Low
2.28
About ORGO
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United St.
Employees
869
Headquarters
Canton, MA
CEO
Mr. Gary S. Gillheeney Sr.
Latest News
Organogenesis Sets Key Q1 Earnings Date: What Investors Should Watch - Stock Titan
2025-04-07 • Google News
Organogenesis: Build On Weakness For Big ReNu Knee OA Payday (NASDAQ:ORGO) - Seeking Alpha
2025-06-04 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg